CNS Pharmaceuticals, Inc. (CNSP) vs Curanex Pharmaceuticals Inc Common Stock (CURX)

A side-by-side comparison of CNS Pharmaceuticals, Inc. and Curanex Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
CNS Pharmaceuticals, Inc. logo
CNSP
CNS Pharmaceuticals, Inc.
$8M
$5.36HealthcareDelayed quote: Oct 6, 2026, 10:49 AM EDT
Curanex Pharmaceuticals Inc Common Stock logo
CURX
Curanex Pharmaceuticals Inc Common Stock
$7M
$5.08HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT

Total return — CNSP vs CURX

growth of $100 · dividends reinvested · last 1y
CNSP -18.9% (-18.9%/yr)CURX -93.8% (-93.8%/yr)CNSP compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002026$81$6
CNSP CURX

CNSP vs CURX: by the numbers

  • •CNSP is the larger company ($8M vs $7M market cap).

Metrics side by side

Valuation

MetricCNSPCURX
P/B ratio0.431.50

Profitability

MetricCNSPCURX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-91.75%-218.65%
ROIC-92.94%-208.39%

Growth (annualized)

MetricCNSPCURX
Total return CAGR (5Y)-91.63%N/A

Go deeper

Full CNSP analysisFull CURX analysisInteractive comparison tool

Dig into the metrics

CNS Pharmaceuticals ROECuranex Pharmaceuticals Inc Common Stock ROECNS Pharmaceuticals operating marginCuranex Pharmaceuticals Inc Common Stock operating marginCNS Pharmaceuticals revenue growthCuranex Pharmaceuticals Inc Common Stock revenue growthCNS Pharmaceuticals free cash flowCuranex Pharmaceuticals Inc Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.